Abbey Jenkins
Direktor/Vorstandsmitglied bei AQUESTIVE THERAPEUTICS, INC.
Vermögen: 10 467 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Abbey Jenkins
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
20
| Subsidiary | Pharmaceuticals: Major | 20 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 14 | |
| Public Company | Pharmaceuticals: Major | 13 | |
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA.
3
| Holding Company | Packaged Software | 3 |
Medimmune, Inc.
2
| Extinct | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Abbey Jenkins
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| ATRECA, INC. | Biotechnology | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer | |
| BARR PHARMACEUTICALS INC | Pharmaceuticals: Generic | Public Communications Contact Director/Board Member Comptroller/Controller/Auditor | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| CGX ENERGY INC. | Oil & Gas Production | Director of Finance/CFO Public Communications Contact | |
| TALISKER RESOURCES LTD. | Precious Metals | Director/Board Member Corporate Secretary | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Chairman Investor Relations Contact | |
Trelawney Mining & Exploration, Inc.
 Trelawney Mining & Exploration, Inc. Precious MetalsNon-Energy Minerals Trelawney Mining & Exploration, Inc. mines for gold and other miscellaneous minerals. The firm's current focus is the exploration and development of the Côté Lake Gold Deposit in the Swayze Greenstone Belt, located halfway between Timmins and Sudbury. The company was founded on July 4, 1996 and is headquartered in Toronto, Canada. | Precious Metals | Director/Board Member Corporate Secretary | |
| Pace University | College/University | Masters Business Admin Undergraduate Degree | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Zacoro Metals Corp.
 Zacoro Metals Corp. Precious MetalsNon-Energy Minerals Zacoro Metals Corp. mines and explores for gold and other metals. It engages in the mining of copper, gold, and zinc. The company is located in Toronto, Canada | Precious Metals | Director of Finance/CFO Corporate Secretary | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| TRICIDA, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FORRESTER METALS INC | Other Metals/Minerals | Director/Board Member Investor Relations Contact | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of San Francisco | College/University | Masters Business Admin Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Chief Investment Officer Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Seton Hall University | College/University | Masters Business Admin Masters Business Admin | |
| Weizmann Institute of Science | College/University | Corporate Officer/Principal Doctorate Degree | |
| COGNITION THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| INSULET CORPORATION | Medical Specialties | Director/Board Member Sales & Marketing | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 40 |
| Kanada | 9 |
| Neuseeland | 2 |
| Finnland | 2 |
| Israel | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 12 |
| Non-Energy Minerals | 5 |
| Commercial Services | 4 |
| Finance | 4 |
Operativ
| Director/Board Member | 325 |
| Corporate Officer/Principal | 168 |
| Independent Dir/Board Member | 117 |
| Director of Finance/CFO | 104 |
| Undergraduate Degree | 60 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jim Fairbairn | 45 |
| Jonathan Silverstein | 42 |
| Scott Rocklage | 32 |
| Ron Hunt | 29 |
| Santo Costa | 28 |
| Paul van Damme | 26 |
| Dan Spiegelman | 24 |
| Julian Adams | 23 |
| Anthony Giovinazzo | 22 |
| Shawn Tomasello | 22 |
| Gregory Brown | 22 |
| Stephen Wills | 22 |
| Timothy Morris | 21 |
| Kenneth Moch | 19 |
| Klaus Veitinger | 18 |
- Börse
- Insiders
- Abbey Jenkins
- Unternehmensverbindungen